Contact Us

News

  • Hon’ble delegation member of CII

    Managing Director Mr. Alok Kumar – Hon’ble delegation member of CII delegation to Minsk Belarus 24th Sept 2018, announced upcoming investment and business with Belarus.

    2018-09-27 14:45:29

  • Onco plant at Goa

    Onco plant at Goa -internal and external infra works are in full swing target to operational by 4th quarter of 2018

    2018-09-27 14:47:06

  • Managing Director Mr. Alok Kumar

    Managing Director Mr. Alok Kumar - Invitee guest during opening of Belarus Consulate at Mumbai

    2018-09-27 14:48:13

  • Plant 1 OSD , 4 Dept

    Plant 1 OSD , 4 Dept, Atgaon, Thane ,India - Russian GMP, Belarus GMP and PIC/s Certified.

    2018-09-27 14:48:45

  • Domestic Market

    3 new products are schedule to launch for Anti fungal, Laxative and Respiratory

    2018-12-04 10:37:57

  • Message 1

    7-Mar-2019 10:00 AM: Opening Ceremony of Novalok LLC (Oral Solid Dose Plant) at Belarus, 31761, Grodno District, SKidel, st. Kizevich 50

    2019-03-07 13:43:05

Quote

  • Competition makes things come out right. Well, what does that mean in health care? More hospitals so they compete with each other. More doctors compete with each other. More pharmaceutical companies. We set up war. Wait a minute, let's talk about the patient. The patient doesn't need a war.
    Donald Berwick

MARKETING / BRANDS

Marketing Brands : Strategically Lok-Beta's key strength and invest significant area based on 3 point agenda

1. Offer opportunities to our associates to run a small to medium sized profitable entrepreneurship by offering them technical know-how with the     empowerment and accountability within the core values and system of the company.

2. Aiming to enable service towards broader segment of the pharmaceuticals & healthcare markets.

3. Marketing strategy - Lok-Beta chooses to market its products which matches its rigorous marketing, stringent quality norms and financial return     criteria.

Methodology : The company has extensive database and obtains regular feedback on customer purchasing patterns and preferences and doctor prescribing habits. These detailed information's are used to direct the company's promotional spend, sales force activity, product development programmes and to identify new product opportunities.

International Market : The company has extensive database and obtains regular feedback on customer purchasing patterns and preferences and doctor prescribing habits. These detailed information's are used to direct the company's promotional spend, sales force activity, product development programmes and to identify new product opportunities.

  • CIS : Armenia, Belarus, Kazakhstan, Kirgizstan, Russia, Tajikistan, Turkmenistan, Ukraine, Uzbekistan
  • Asia Pacific: Bhutan, Sri-Lanka, Myanmar, Philippines, Thailand, Vietnam, Yemen, Malaysia, Indonesia, Singapore
  • Latin America: Bolivia, Guatemala, Paraguay, Trinidad, Brazil, Colombia, Argentina, Nicaragua, Chili, Costa Rica
  • Africa: Ethiopia, Namibia, Nigeria

Domestic Market : Branch offices at 4 state enable expending own domestic business in Maharashtra, Uttar-Pradesh, Bihar and Jharkhand. Aggressive plan for PAN India operation are under implementation.

Brands :

  • Lok-Beta has launched new products in the market such as Movnic D Plus, Kouf – X DS, Lozit Suspension and planning to launch products of niche segments.
  • Lok-Beta is a key player in the Indian market, with a wide range of products in various segments such as Antiinflammatory, Neutraceuticals, Antimalarial and Antihypertensive.
  • Lok-Beta enjoys a strong rapport with the medical profession including specialist, who have accepted Lok-Beta's product for their High quality, efficacy and affordability.
  • Lok-Beta has built up a strong equity with a vast and efficient DEALER NETWORK.